160 related articles for article (PubMed ID: 9335362)
1. LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.
Bosch T; Schmidt B; Kleophas W; Otto V; Samtleben W
Artif Organs; 1997 Oct; 21(10):1060-5. PubMed ID: 9335362
[TBL] [Abstract][Full Text] [Related]
2. LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood.
Bosch T; Schmidt B; Kleophas W; Gillen C; Otto V; Passlick-Deetjen J; Gurland HJ
Artif Organs; 1997 Sep; 21(9):977-82. PubMed ID: 9288867
[TBL] [Abstract][Full Text] [Related]
3. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.
Bosch T; Lennertz A; Schmidt B; Fink E; Keller C; Toepfer M; Dräger J; Samtleben W
Artif Organs; 2000 Feb; 24(2):81-90. PubMed ID: 10718759
[TBL] [Abstract][Full Text] [Related]
4. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood.
Bosch T; Schmidt B; Blumenstein M; Gurland HJ
Artif Organs; 1993 Jul; 17(7):640-52. PubMed ID: 8338441
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: a prospective controlled clinical trial.
Bosch T; Heinemann O; Duhr C; Wendler T; Keller C; Fink E; Kirschner T; Klebert S; Samtleben W
Artif Organs; 2000 Oct; 24(10):790-6. PubMed ID: 11091168
[TBL] [Abstract][Full Text] [Related]
6. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center.
Bosch T; Lennertz A; Kordes B; Samtleben W
Ther Apher; 1999 Aug; 3(3):209-13. PubMed ID: 10427617
[TBL] [Abstract][Full Text] [Related]
7. Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility.
Wendler T; Lennertz A; Heinemann O; Duhr C; Samtleben W; Bosch T
Int J Artif Organs; 2000 Oct; 23(10):710-7. PubMed ID: 11075902
[TBL] [Abstract][Full Text] [Related]
8. Direct adsorption of lipoproteins from whole blood by DALI apheresis: technique and effects.
Bosch T
Ther Apher; 2001 Aug; 5(4):239-43. PubMed ID: 11724507
[TBL] [Abstract][Full Text] [Related]
9. Modified DALI LDL-apheresis using trisodium citrate anticoagulation plus bicarbonate or lactate-buffered hemofiltration substitution fluids as primers.
Bosch T; Wendler T; Maschke H
Artif Organs; 2003 Jun; 27(6):555-64. PubMed ID: 12780510
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results.
Bosch T
Artif Organs; 1996 Apr; 20(4):344-5. PubMed ID: 9139622
[TBL] [Abstract][Full Text] [Related]
11. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of LDL apheresis by hemoperfusion (DALI) and heparin-induced extracorporeal precipitation (HELP) on leukocyte respiratory burst activity of patients with familial hypercholesterolemia.
Kopprasch S; Julius U; Gromeier S; Kühne H; Graessler J
J Clin Apher; 2000; 15(4):249-55. PubMed ID: 11124693
[TBL] [Abstract][Full Text] [Related]
13. High-efficiency DALI apheresis using 1,250 ml adsorbers in a hypercholesterolemic obese patient: a case report.
Bosch T; Lennertz A; Samtleben W
Ther Apher; 2001 Oct; 5(5):358-63. PubMed ID: 11778920
[TBL] [Abstract][Full Text] [Related]
14. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis.
Bosch T
Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure.
Bosch T; Thiery J; Gurland HJ; Seidel D
Nephrol Dial Transplant; 1993; 8(12):1350-8. PubMed ID: 8159304
[TBL] [Abstract][Full Text] [Related]
16. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo biocompatibility of avidin-agarose: a new device for direct adsorption of biotinylated antibodies from human whole blood.
Bosch T; Lennertz A; Duhr C; Fink E; Samtleben W
Artif Organs; 2000 Sep; 24(9):696-704. PubMed ID: 11012539
[TBL] [Abstract][Full Text] [Related]
18. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions.
Bosch T; Gahr S; Belschner U; Schaefer C; Lennertz A; Rammo J;
Ther Apher Dial; 2006 Jun; 10(3):210-8. PubMed ID: 16817783
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
[TBL] [Abstract][Full Text] [Related]
20. DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results.
Dräger LJ; Julius U; Kraenzle K; Schaper J; Toepfer M; Zygan K; Otto V; Steinhagen-Thiessen E
Eur J Clin Invest; 1998 Dec; 28(12):994-1002. PubMed ID: 9893010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
